Fierce Healthcare11h
Trump's CMS signals flexibility on Medicare drug price negotiation, sparking new questions for RFK Jr.
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
Independent Record12h
Montana Medicaid: How Trump and GOP-led Congress could alter health care for thousands
Congress and Republican President Donald Trump have made it clear they intend to consider far-reaching policies to limit the ...
RFK Jr. Confused Medicare and Medicaid: Here's the Difference
The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them if confirmed. We ...
STAT15h
Pharmalittle: We’re reading about the RFK Jr. confirmation hearings, CMS plans for drug-pricing talks, and more
In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and ...
JD Supra12h
Navigating the Health Care Impacts of President Trump's First Executive Actions
Since taking office for his second term on Jan. 20, 2025, President Donald Trump has issued a series of executive orders (EOs) aimed at ...
CMS's $41 Million Audit Award Stands Despite Flawed Discussions
Healthcare Management Solutions LLC can perform a $41 million auditing services task order for the Centers of Medicare and Medicaid Services despite the agency’s improper discussions, the US Court of ...
Medscape18h
Unsustainable Biosimilar Market Leaves Practices, Patients at a Loss
The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
JD Supra11h
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...